ArticleGlobalization and health2021
An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
Article in Globalization and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- A comparative systematic review of risk factors, prevalence, and challenges contributing to non-communicable diseases in South Asia, Africa, and Caribbeans.Journal of health, population, and nutrition · 2024Pooled it
- [Evolution and Application of Disease Control Priorities].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024Pooled it
- Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review.PLoS medicine · 2022Pooled it
- A Culturally Sensitive and Theory-Based Intervention on Prevention and Management of Diabetes: A Cluster Randomized Control Trial.Nutrients · 2022Trial
- Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023.The Lancet. Oncology · 2026Article
- CARDIO4Cities: A roadmap for improving urban cardiovascular health.American journal of preventive cardiology · 2026Article
- Prevention in stroke - Current state, present gaps and probable next steps.Neurological research and practice · 2026Review
- Prolonged multisectoral aid-driven reliance on health systems and governance post-conflict era in Somalia.Tropical medicine and health · 2026Review
- Private capital in a public field: a qualitative study of philanthropic influence in Germany's global health governance.Frontiers in public health · 2026Article
- Navigating power in policy adoption: The political economy of noncommunicable diseases in Sierra Leone.SSM - health systems · 2025Article
- The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.Lancet (London, England) · 2025Article
- Multifaceted barriers associated with clinical breast examination in sub-Saharan Africa: A multilevel analytical approach.PloS one · 2025Article
- Towards Implementation of Equitable and Effective Non-Communicable Disease Policies Comment on "Barriers and Opportunities for WHO 'Best Buys' Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review".International journal of health policy and management · 2025Article
- Strengthening United Nations country support on non-communicable diseases and mental health: an analysis of United Nations Sustainable Development Cooperation Frameworks.Frontiers in public health · 2025Article
- Factors influencing non-communicable disease policy process in Sub-Saharan Africa: a scoping review.BMJ public health · 2025Article
- Promoting Global Cardiovascular Health to Advance the Sustainable Development Agenda.JACC. Advances · 2024Review
- Economic and healthcare influences on circulatory diseases in Kazakhstan: a retrospective ecological study.Journal of health, population, and nutrition · 2024Article
- The financial burden of noncommunicable diseases from out-of-pocket expenditure in sub-Saharan Africa: a scoping review.Health promotion international · 2024Article
- Household economic burden of type-2 diabetes and hypertension comorbidity care in urban-poor Ghana: a mixed methods study.BMC health services research · 2024Article
- Reorienting health systems towards Primary Health Care in South Asia.The Lancet regional health. Southeast Asia · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNoncommunicable diseases (NCDs), including mental health, have become a major concern in low- and middle-income countries. Despite increased attention to them over the past decade, progress toward addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one of the contributors to limited progress in NCD prevention and management. However, the policies of key global actors (bilateral, multilateral, and not-for-profit organisations) have been understudied.
methodsThis study aimed to map the key global actors investing in action regarding NCDs and review their policies to examine the articulation of priorities regarding NCDs. Narrative synthesis of 70 documents and 31 policy papers was completed, and related to data collated from the Global Health Data Visualisation Tool.
resultsIn 2019 41% of development assistance for health committed to NCDs came from private philanthropies, while that for other global health priorities from this source was just 20%. Through a range of channels, bilateral donors were the other major source of NCD funding (contributing 41% of NCD funding). The UK and the US were the largest bilateral investors in NCDs, each contributing 8%. However, NCDs are still under-prioritised within bilateral portfolios - receiving just 0.48% of US funding and 1.66% of the UK. NGOs were the key channels of funding for NCDs, spending 48% of the funds from donors in 2019. The reviewed literature generally focused on NCD policies of WHO, with policies of multilateral and bilateral donors given limited attention. The analysis of policies indicated a limited prioritisation of NCDs in policy documents. NCDs are framed in the policies as a barrier to economic growth, poverty reduction, and health system sustainability. Bilateral donors prioritise prevention, while multilateral actors offer policy options for NCD prevention and care. Even where stated as a priority, however, funding allocations are not aligned.
conclusionThe growing threat of NCDs and their drivers are increasingly recognised. However, global actors' policy priorities and funding allocations need to align better to address these NCD threats. Given the level of their investment and engagement, more research is needed into the role of private philanthropies and NGOs in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.